Alistair Nichol

Professor

20052024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Alistair is an Associate Professor in the ANZIC-RC, School of Public Health and Preventive Medicine, Monash University, and a consultant intensivist in The Alfred Hospital, Melbourne. Following completion of a PhD at University College Dublin, Alistair commenced with the ANZIC-RC in 2007 and has worked on a number of its large multi-centre randomised controlled trials. He is currently one of the Chief Investigators on the EPO-TBI (Erythropoietin in Traumatic Brain Injury) Study and is actively involved with the POLAR-RCT (Prophylactic hypOthermia trail to Lessen trAumatic bRain injury Randomised Control Trial) Study and the PHARLAP Study. His areas of interest include traumatic brain injury (TBI), acute respiratory distress syndrome (ARDS) and mechanical ventilation. Alistair has completed over 10 years of training in Anaesthesia, Intensive Care and Pain Medicine. He was awarded the Fellowship of the College of Anaesthetists, Royal College of Surgeons Ireland (FCARCSI) in 2002, and the Fellowship of the College of Intensive Care Medicine Australia and New Zealand (FCICM) in 2010. Alistair is also a Victorian Neurotrauma Initiative (VNI) Early Career Practitioner Fellow.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Effect of Stress Ulcer Prophylaxis with Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial

The PEPTIC Investigators & for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group, 17 Jan 2020, In : JAMA - Journal of the American Medical Association. 323, 7, p. 616-626 11 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study

McMahon, B. A., Galligan, M., Redahan, L., Martin, T., Meaney, E., Cotter, E. J., Murphy, N., Hannon, C., Doran, P., Marsh, B., Nichol, A. & Murray, P. T., 1 Jul 2019, In : American Journal of Nephrology. 50, 1, p. 19-28 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial

Skrifvars, M. B., Moore, E., Mårtensson, J., Bailey, M., French, C., Presneill, J., Nichol, A., Little, L., Duranteau, J., Huet, O., Haddad, S., Arabi, Y., McArthur, C., Cooper, D. J., Bellomo, R. & The EPO-TBI Investigators and the ANZICS Clinical Trials Group, Feb 2019, In : Acta Anaesthesiologica Scandinavica. 63, 2, p. 200-207 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Fresh red cells for transfusion in critically ill adults: an economic evaluation of the Standard Issue Transfusion versus Fresher Red-Cell Use in Intensive Care (TRANSFUSE) clinical trial

Irving, A., Higgins, A., Ady, B., Bellomo, R., Cooper, D. J., French, C., Gantner, D., Harris, A., Irving, D. O., Murray, L., Nichol, A., Petrie, D., McQuilten, Z. K. & on behalf of the Standard Issue Transfusion versus Fresher Red-Cell Use in Intensive Care (TRANSFUSE) Investigators and Australian and New Zealand Intensive Care Society Clinical Trials Group, 1 Jul 2019, In : Critical Care Medicine. 47, 7, p. e572-e579 8 p.

Research output: Contribution to journalArticleResearchpeer-review